DNA methylation profiles within the serotonin transporter gene moderate the association of 5-HTTLPR and cortisol stress reactivity

Translational Psychiatry

Volumn 4, Issue 9, 2014, Pages

  Alexander, N ^a   Wankerl, M ^a   Hennig, J ^b   Miller, R ^a   Zankert S ^c   Steudte Schmiedgen, S ^d   Stalder, T ^a   Kirschbaum, C ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; SEROTONIN TRANSPORTER; SEROTONIN TRANSPORTER GENE LINKED POLYMORPHIC REGION; UNCLASSIFIED DRUG; SLC6A4 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CPG ISLAND; DNA METHYLATION; FEMALE; FUNCTION TEST; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PYROSEQUENCING; STRESS; TRIER SOCIAL STRESS TEST; ADOLESCENT; ANALYSIS OF VARIANCE; GENETICS; MENTAL STRESS; METABOLISM; SALIVA; YOUNG ADULT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; DNA METHYLATION; FEMALE; HUMANS; HYDROCORTISONE; MALE; SALIVA; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84927796681     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.88     Document Type: Article

References (104)

1. Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, Scott RJ et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 2008; 17: 1156-1168.
2. Beveridge NJ, Gardiner E, Carroll AP, Tooney PA, Cairns MJ. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 2010; 15: 1176-1189.
3. Carroll AP, Tooney PA, Cairns MJ. Context-specific microRNA function in developmental complexity. J Mol Cell Biol 2013; 5: 73-84.
4. Maiorano NA, Mallamaci A. Promotion of embryonic cortico-cerebral neuronogenesis by miR-124. Neural Dev 2009; 4: 1-16.
5. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brainexpressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 2004; 5: R13.
6. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M et al. A brainspecific microRNA regulates dendritic spine development. Nature 2006; 439: 283-289.
7. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006; 125: 1111-1124.
8. Uchida S, Nishida A, Hara K, Kamemoto T, Suetsugi M, Fujimoto M et al. Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur J Neurosci 2008; 27: 2250-2261.
9. Meerson A, Cacheaux L, Goosens KA, Sapolsky RM, Soreq H, Kaufer D. Changes in brain microRNAs contribute to cholinergic stress reactions. J Mol Neurosci 2010; 40: 47-55.
10. Rice D, Barone Jr. S.Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 2000; 108(Suppl)):511-533.
11. Stead JDH, Neal C, Meng F, Wang Y, Evans S, Vazquez DM et al. Transcriptional profiling of the developing rat brain reveals that the most dramatic regional differentiation in gene expression occurs postpartum. J Neurosci 2006; 26: 345-353.
12. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153: 321-330.
13. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the 'right stuff'? Schizophr Bull 2000; 26: 119-136.
14. Jakob H, Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 1986; 65: 303-326.
15. Arnold SE, Ruscheinsky DD, Han LY. Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol Psychiatry 1997; 42: 639-647.
16. Schultz CC, Koch K, Wagner G, Roebel M, Schachtzabel C, Nenadic I et al. Psychopathological correlates of the entorhinal cortical shape in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2010; 260: 351-358.
17. Joyal CC, Laakso MP, Tiihonen J, Syva E, Vilkman H, Laakso A et al. A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia. Biol Psychiatry 2002; 51: 1005-1007.
18. Baiano M, Perlini C, Rambaldelli G, Cerini R, Dusi N, Bellani M et al. Decreased entorhinal cortex volumes in schizophrenia. Schizophr Res 2008; 102: 171-180.
19. Prasad KMR, Patel AR, Muddasani S, Sweeney J, Keshavan MS. The entorhinal cortex in first-episode psychotic disorders: a structural magnetic resonance imaging study. Am J Psychiatry 2004; 161: 1612-1619.
20. Piontkewitz Y, Arad M, Weiner I. Tracing the development of psychosis and its prevention: what can be learned from animal models. Neuropharmacology 2012; 62: 1273-1289.
21. Piontkewitz Y, Arad M, Weiner I. Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat. Biol Psychiatry 2011; 70: 842-851.
22. Zuckerman L, Rehavi M, Nachman R, Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 2003; 28: 1778-1789.
23. Zuckerman L, Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 2005; 39: 311-323.
24. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 2008; 22: 469-486.
25. Weiner I. The 'two-headed' latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl) 2003; 169: 257-297.
26. Bronson SL, Ahlbrand R, Horn PS, Kern JR, Richtand NM. Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors. Behav Brain Res 2011; 220: 55-64.
27. Fatemi SH, Folsom TD, Rooney RJ, Mori S, Kornfield TE, Reutiman TJ et al. The viral theory of schizophrenia revisited: Abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae or brains of exposed offspring from infected mice. Neuropharmacology 2011; 62: 1290-1298.
28. Smith SEP, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007; 27: 10695-10702.
29. Stolp HB, Turnquist C, Dziegielewska KM, Saunders NR, Anthony DC, Molnar Z. Reduced ventricular proliferation in the foetal cortex following maternal inflammation in the mouse. Brain 2011; 134: 3236-3248.
30. Ellman LM, Deicken RF, Vinogradov S, Kremen WS, Poole JH, Kern DM et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res 2010; 121: 46-54.
31. Catts VS, Fung SJ, Long LE, Joshi D, Vercammen A, Allen KM et al. Rethinking schizophrenia in the context of normal neurodevelopment. Front Cell Neurosci 2013; 7: 60.
32. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000; 24: 417-463.
33. Dudley KJ, Li X, Kobor MS, Kippin TE, Bredy TW. Epigenetic mechanisms mediating vulnerability and resilience to psychiatric disorders. Neurosci Biobehav Rev 2011; 35: 1544-1551.
34. Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S et al. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 2006; 49: 67-79.
35. Trezza V, Campolongo P, Manduca A, Morena M, Palmery M, Vanderschuren LJMJ et al. Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. Front Behav Neurosci 2012; 6: 2.
36. Little PJ, Compton DR, Mechoulam R, Martin BR. Stereochemical effects of in mice and dogs. Pharmacol Biochem Behav 1989; 32: 661-666.
37. Dewey WL. Cannabinoid pharmacology. Pharmacol Rev 1986; 38: 151-178.
38. Giuliani D, Ferrari F, Ottani A. The cannabinoid agonist Hu 210 modifies rat behavioural responses to novelty and stress. Pharmacol Res 2000; 41: 45-51.
39. Ottani A, Giuliani D. HU 210: a potent tool for investigations of the cannabinoid system. CNS Drug Rev 2001; 7: 131-145.
40. Reilly D, Didcott P, Swift W, Hall W. Long-Term cannabis use: characteristics of users in an Australian rural area. Addiction 1998; 93: 837-846.
41. Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001; 178: 101-106.
42. Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005; 31: 608-612.
43. Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-328.
44. Bayer TA, Falkai P, Maier W. Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the 'two hit hypothesis'. J Psychiatr Res 1999; 33: 543-548.
45. Maynard TM, Sikich L, Lieberman JA, LaMantia AS. Neural development, cell-cell signaling, and the 'two-hit' hypothesis of schizophrenia. Schizophr Bull 2001; 27: 457-476.
46. Dalton VS, Verdurand M, Walker A, Hodgson DM, Zavitsanou K. Synergistic effect between maternal infection and adolescent cannabinoid exposure on serotonin 5HT1A receptor binding in the hippocampus: testing the 'two hit' hypothesis for the development of schizophrenia. ISRN Psychiatry 2012; 2012: 1-9.
47. Dalton VS, Zavitsanou K. Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210. Synapse 2010; 64: 845-854.
48. Rodriguez de Fonseca F, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF et al. Corticotropin-releasing factor (CRF) antagonist [D-Phel2, Nle21, 38, CaMe-Leu37]CRF attenuates the acute actions of receptor agonist HU-210 on defensive-withdrawal behavior in rats1. J Pharmacol Exp Ther 1996; 276: 56-64.
49. Paxino G Watson C. In: Poncelet, M, Chermat, R, Soubrie, P, Simon, P (eds). 6th edn, San Diego: Academic Press, 1998.
50. Wu JQ, Wang X, Beveridge NJ, Tooney PA, Scott RJ, Carr VJ et al. Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. PLoS ONE 2012; 7: e36351.
51. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006; 7: 3.
52. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
53. Santarelli DM, Beveridge NJ, Tooney PA, Cairns MJ. Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry 2011; 69: 180-187.
54. Chang JT, Nevins JR. GATHER: a systems approach to interpreting genomic signatures. Bioinformatics 2006; 22: 2926-2933.
55. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868.
56. Saldanha AJ. Java Treeview-extensible visualization of microarray data. Bioinformatics 2004; 20: 3246-3248.
57. Beveridge NJ, Gardiner E, Carroll P, Tooney P, Cairns MJ. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 2010, 15: 1176-1189.
58. Gardiner E, Beveridge NJ, Wu JQ, Carr V, Scott RJ, Tooney PA et al. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-Associated miRNA signature in peripheral blood mononuclear cells. Mol Psychiatry 2012; 17: 827-840.
59. Seitz H, Royo H, Bortolin M-L, Lin S-P, Ferguson-Smith AC, Cavaille J. A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res 2004; 14: 1741-1748.
60. Fiore R, Khudayberdiev S, Christensen M, Siegel G, Flavell SW, Kim T-K et al. Mef2-mediated transcription of the miR379-410 cluster regulates activitydependent dendritogenesis by fine-Tuning Pumilio2 protein levels. EMBO J 2009; 28: 697-710.
61. Oertel-Knochel V, Linden DEJ. Cerebral asymmetry in schizophrenia. Neuroscientist 2011; 17: 456-467.
62. Best C, Lange E, Buchholz H-G, Schreckenberger M, Reuss S, Dieterich M. Left hemispheric dominance of vestibular processing indicates lateralization of cortical functions in rats. Brain Struct Funct advance online publication, 1 August 2013; doi:10.1007/s00429-013-0628.
63. Inberg S, Elkobi A, Edri E, Rosenblum K. Taste familiarity is inversely correlated with Arc/Arg3.1 hemispheric lateralization. J Neurosci 2013; 33: 11734-11743.
64. Wu H, Wang C, Wang X, Wang L, Chang C, Wang P et al. Correlations between angiotensinase activity asymmetries in the brain and paw preference in rats. Neuropeptides 2010; 44: 253-259.
65. Alqadah A, Hsieh Y-W, Chuang C-F. microRNA function in left-right neuronal asymmetry: perspectives from C. elegans. Front Cell Neurosci 2013; 7: 158.
66. Olsen L, Klausen M, Helboe L, Nielsen FC, Werge T. MicroRNAs show mutually exclusive expression patterns in the brain of adult male rats. PLoS ONE 2009; 4: e7225.
67. Skutella T, Nitsch R. New molecules for hippocampal development. Trends Neurosci 2001; 24: 107-113.
68. Kim J, Krichevsky A, Grad Y, Hayes GD, Kosik KS, Church GM et al. Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. PNAS 2004; 101: 360-365.
69. Manakov SA, Grant SGN, Enright AJ. Reciprocal regulation of microRNA and mRNA profiles in neuronal development and synapse formation. BMC Genomics 2009; 10: 419.
70. Royo H, Cavaille J. Non-coding RNAs in imprinted gene clusters. Biol Cell 2008; 100: 149-166.
71. Seitz H, Youngson N, Lin S-P, Dalbert S, Paulsen M, Bachellerie J-P et al. Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. Nat Genet 2003; 34: 261-262.
72. Davis E, Caiment F, Tordoir X, Cavaille J, Ferguson-Smith A, Cockett N et al. RNAimediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus. Curr Biol 2005; 15: 743-749.
73. Byrne K, Colgrave ML, Vuocolo T, Pearson R, Bidwell CA, Cockett NE et al. The imprinted retrotransposon-like gene PEG11 (RTL1) is expressed as a full-length protein in skeletal muscle from Callipyge sheep. PLoS ONE 2010; 5: e8638.
74. Cichon S, Schumacher J, Muller DJ, Hurter M, Windemuth C, Strauch K et al. A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet 2001; 10: 2933-2944.
75. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI et al. Genome scan meta-Analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 2003; 73: 49-62.
76. Middeldorp CM, Hottenga J-J, Slagboom PE, Sullivan PF, de Geus EJC, Posthuma D et al. Linkage on chromosome 14 in a genome-wide linkage study of a broad anxiety phenotype. Mol Psychiatry 2008; 13: 84-89.
77. Laufer BI, Mantha K, Kleiber ML, Diehl EJ, Addison SMF, Singh SM. Long-lasting alterations to DNA methylation and ncRNAs could underlie the effects of fetal alcohol exposure in mice. Dis Model Mech 2013; 6: 977-992.
78. Elmer BM, Estes ML, Barrow SL, McAllister AK. MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease. J Neurosci 2013; 33: 13791-13804.
79. Flavell SW, Kim T-K, Gray JM, Harmin DA, Hemberg M, Hong EJ et al. Genomewide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 2008; 60: 1022-1038.
80. Leifer D, Golden J, Kowall NW. Myocyte-specific enhancer binding factor 2C expression in human brain development. Neuroscience 1994; 63: 1067-1079.
81. Akhtar MW, Kim M-S, Adachi M, Morris MJ, Qi X, Richardson JA et al. In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. PLoS ONE 2012; 7: e34863.
82. Li H, Radford JC, Ragusa MJ, Shea KL, McKercher SR, Zaremba JD et al. Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo. Proc Natl Acad Sci USA 2008; 105: 9397-9402.
83. Bayer SA, Altman J, Russo RJ, Zhang X. Timetables of neurogenesis in the human brain based on experimentally determermined patterns in the rat. Neurotoxicology 1993; 14: 83-144.
84. Deng MY, Lam S, Meyer U, Feldon J, Li Q, Wei R et al. Frontal-subcortical protein expression following prenatal exposure to maternal inflammation. PLoS ONE 2011; 6: e16638.
85. Kyosseva S V, Elbein AD, Griffin WS, Mrak RE, Lyon M, Karson CN. Mitogenactivated protein kinases in schizophrenia. Biol Psychiatry 1999; 46: 689-696.
86. Samuels IS, Karlo JC, Faruzzi AN, Pickering K, Herrup K, Sweatt JD et al. Deletion of ERK2 mitogen-Activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function. J Neurosci 2008; 28: 6983-6995.
87. Hebert AE, Dash PK. Extracellular signal-regulated kinase activity in the entorhinal cortex is necessary for long-Term spatial memory. Learn Mem 2002; 9: 156-166.
88. Parsons MJ, Grimm CH, Paya-Cano JL, Sugden K, Nietfeld W, Lehrach H et al. Using hippocampal microRNA expression differences between mouse inbred strains to characterise miRNA function. Mamm Genome 2008; 19: 552-560.
89. Gao J, Wang W-Y, Mao Y-W, Graff J, Guan J-S, Pan L et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010; 466: 1105-1109.
90. Carroll LS, Williams HJ, Walters J, Kirov G, Donovan MCO, Owen MJ et al. Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia. Am J Med Genet 2011; 844-849.
91. Van Beveren NJM, Buitendijk GHS, Swagemakers S, Krab LC, Roder C, de Haan L et al. Marked reduction of AKT1 expression and deregulation of AKT1-Associated pathways in peripheral blood mononuclear cells of schizophrenia patients. PLoS ONE 2012; 7: e32618.
92. Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-Analysis. Mol Psychiatry 2011; 16: 960-972.
93. Udawela M, Scarr E, Hannan AJ, Thomas EA, Dean B. Phospholipase C beta 1 expression in the dorsolateral prefrontal cortex from patients with schizophrenia at different stages of illness. Aust N Z J Psychiatry 2011; 45: 140-147.
94. Cotter D, Kerwin R, Al-Sarraji S, Brion JP, Chadwich A, Lovestone S et al. Abnormalities of Wnt signalling in schizophrenia-evidence for neurodevelopmental abnormality. Neuroreport 1998; 9: 1379-1383.
95. Miyaoka T, Seno H, Ishino H. Increased expression of Wnt-1 in schizophrenic brains. Schizophr Res 1999; 38: 1-6.
96. Gogolla N, Galimberti I, Deguchi Y, Caroni P. Wnt signaling mediates experiencerelated regulation of synapse numbers and mossy fiber connectivities in the adult hippocampus. Neuron 2009; 62: 510-525.
97. Kumamoto N, Gu Y, Wang J, Janoschka S, Takemaru K-I, Levine J et al. A role for primary cilia in glutamatergic synaptic integration of adult-born neurons. Nat Neurosci 2012; 15: 399-405.
98. Maguschak KA, Ressler KJ. Wnt signaling in amygdala-dependent learning and memory. J Neurosci 2011; 31: 13057-13067.
99. Tabatadze N, Tomas C, McGonigal R, Lin B, Schook A, Routtenberg A. Wnt transmembrane signaling and long-Term spatial memory. Hippocampus 2012; 22: 1228-1241.
100. Molteni R, Calabrese F, Racagni G, Fumagalli F, Riva MA. Antipsychotic drug actions on gene modulation and signaling mechanisms. Pharmacol Ther 2009; 124: 74-85.
101. Ishima T, Iyo M, Hashimoto K. Neurite outgrowth mediated by the heat shock protein Hsp90a: a novel target for the antipsychotic drug aripiprazole. Transl Psychiatry 2012; 2: e170.
102. Kato Y, Kravchenko V V, Tapping RI, Han J, Ulevitch RJ, Lee J. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J 1997; 16: 7054-7066.
103. Barbosa AC, Kim M-S, Ertunc M, Adachi M, Nelson ED, McAnally J et al. MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc Natl Acad Sci USA 2008; 105: 9391-9396.
104. Carroll AP, Tran N, Tooney PA, Cairns MJ. Alternative mRNA fates identified in microRNA-Associated transcriptome analysis. BMC Genomics 2012; 13: 561.